ChemioCare is a pharmaceutical company working on a proprietary transdermal delivery platform.
Focused on improving quality of life and outcomes for patients undergoing cancer treatment, we believe that there is a significant opportunity to improve the profiles of generic medicines included in the standard of care by using transdermal technology.
